Harvard Management as of Dec. 31, 2021
Portfolio Holdings for Harvard Management
Harvard Management holds 46 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scientific Games (LNW) | 16.8 | $179M | 2.7M | 66.83 | |
| Alphabet Cap Stk Cl A (GOOGL) | 16.6 | $177M | 61k | 2897.04 | |
| Royalty Pharma Shs Class A (RPRX) | 13.0 | $138M | 3.5M | 39.85 | |
| Meta Platforms Cl A (META) | 11.7 | $125M | 372k | 336.35 | |
| Abcellera Biologics (ABCL) | 5.5 | $59M | 4.1M | 14.30 | |
| Eqrx | 3.4 | $36M | 5.3M | 6.82 | |
| 10x Genomics Cl A Com (TXG) | 2.6 | $28M | 186k | 148.96 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.4 | $26M | 1.5M | 17.13 | |
| Affirm Hldgs Com Cl A (AFRM) | 1.6 | $18M | 174k | 100.56 | |
| Revolution Medicines (RVMD) | 1.6 | $17M | 670k | 25.17 | |
| Relay Therapeutics (RLAY) | 1.6 | $17M | 541k | 30.71 | |
| Praxis Precision Medicines I | 1.4 | $15M | 779k | 19.70 | |
| Grab Holdings Class A Ord (GRAB) | 1.3 | $14M | 2.0M | 7.13 | |
| Tenaya Therapeutics (TNYA) | 1.2 | $13M | 673k | 18.95 | |
| Rocket Lab Usa | 1.2 | $12M | 1.0M | 12.28 | |
| Meli Kaszek Pioneer Corp Class A Ord | 1.1 | $12M | 1.0M | 11.56 | |
| Purecycle Technologies (PCT) | 1.0 | $10M | 1.1M | 9.57 | |
| Confluent Class A Com (CFLT) | 0.9 | $9.9M | 130k | 76.24 | |
| Micron Technology (MU) | 0.9 | $9.6M | 103k | 93.15 | |
| Nurix Therapeutics (NRIX) | 0.9 | $9.1M | 315k | 28.95 | |
| Lam Research Corporation | 0.8 | $9.0M | 13k | 719.11 | |
| Kinnate Biopharma | 0.8 | $8.8M | 498k | 17.72 | |
| Applied Materials (AMAT) | 0.7 | $8.0M | 51k | 157.36 | |
| Advanced Micro Devices (AMD) | 0.7 | $7.9M | 55k | 143.89 | |
| Intel Corporation (INTC) | 0.7 | $7.8M | 151k | 51.50 | |
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.7 | $7.8M | 64k | 120.31 | |
| Tango Therapeutics (TNGX) | 0.7 | $7.8M | 708k | 10.94 | |
| NVIDIA Corporation (NVDA) | 0.7 | $7.7M | 26k | 294.13 | |
| Pliant Therapeutics (PLRX) | 0.7 | $7.6M | 562k | 13.50 | |
| Qorvo (QRVO) | 0.7 | $7.3M | 47k | 156.40 | |
| Analog Devices (ADI) | 0.7 | $7.3M | 42k | 175.76 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $7.3M | 411k | 17.69 | |
| Sana Biotechnology (SANA) | 0.7 | $7.3M | 469k | 15.48 | |
| Asml Holding N V N Y Registry Shs (ASML) | 0.7 | $7.2M | 9.0k | 796.10 | |
| Xilio Therapeutics (XLO) | 0.6 | $6.7M | 416k | 16.00 | |
| Pardes Biosciences | 0.6 | $6.5M | 400k | 16.37 | |
| Surrozen | 0.5 | $5.3M | 827k | 6.44 | |
| Pacific Biosciences of California (PACB) | 0.4 | $4.7M | 229k | 20.46 | |
| Generation Bio | 0.3 | $3.6M | 510k | 7.08 | |
| Decibel Therapeutics | 0.1 | $1.5M | 329k | 4.65 | |
| Magenta Therapeutics | 0.1 | $1.5M | 333k | 4.43 | |
| Dyne Therapeutics (DYN) | 0.1 | $1.3M | 107k | 11.89 | |
| Seres Therapeutics | 0.1 | $1.1M | 132k | 8.33 | |
| Gemini Therapeutics | 0.1 | $728k | 250k | 2.91 | |
| Dada Nexus Ads | 0.0 | $531k | 40k | 13.16 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $125k | 108k | 1.15 |
